233 related articles for article (PubMed ID: 15679285)
1. Myocardial reperfusion injury: etiology, mechanisms, and therapies.
Hoffman JW; Gilbert TB; Poston RS; Silldorff EP
J Extra Corpor Technol; 2004 Dec; 36(4):391-411. PubMed ID: 15679285
[TBL] [Abstract][Full Text] [Related]
2. The role of neutrophils in myocardial ischemia-reperfusion injury.
Jordan JE; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 1999 Sep; 43(4):860-78. PubMed ID: 10615413
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury.
Kaminski KA; Bonda TA; Korecki J; Musial WJ
Int J Cardiol; 2002 Nov; 86(1):41-59. PubMed ID: 12243849
[TBL] [Abstract][Full Text] [Related]
4. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
[TBL] [Abstract][Full Text] [Related]
5. Progressive thermopreconditioning attenuates rat cardiac ischemia/reperfusion injury by mitochondria-mediated antioxidant and antiapoptotic mechanisms.
Chien CY; Chien CT; Wang SS
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):705-13. PubMed ID: 24507988
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.
Wang Y; Li X; Wang X; Lau W; Wang Y; Xing Y; Zhang X; Ma X; Gao F
PLoS One; 2013; 8(8):e70956. PubMed ID: 23976968
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms and pathways in myocardial reperfusion injury.
Valikeserlis I; Athanasiou AA; Stakos D
Coron Artery Dis; 2021 Sep; 32(6):567-577. PubMed ID: 33471478
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies.
Bagheri F; Khori V; Alizadeh AM; Khalighfard S; Khodayari S; Khodayari H
Life Sci; 2016 Nov; 165():43-55. PubMed ID: 27667751
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants and myocardial ischemia: reperfusion injuries.
Chen JK; Chow SE
Chang Gung Med J; 2005 Jun; 28(6):369-77. PubMed ID: 16124152
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
[TBL] [Abstract][Full Text] [Related]
12. Tilianin Post-Conditioning Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondrial Protection and Inhibition of Apoptosis.
Wang Y; Yuan Y; Wang X; Wang Y; Cheng J; Tian L; Guo X; Qin D; Cao W
Med Sci Monit; 2017 Sep; 23():4490-4499. PubMed ID: 28922345
[TBL] [Abstract][Full Text] [Related]
13. Hongjingtian injection protects against myocardial ischemia reperfusion-induced apoptosis by blocking ROS induced autophagic- flux.
Zhao J; Zhang J; Liu Q; Wang Y; Jin Y; Yang Y; Ni C; Zhang L
Biomed Pharmacother; 2021 Mar; 135():111205. PubMed ID: 33395603
[TBL] [Abstract][Full Text] [Related]
14. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
Townsend PA; Davidson SM; Clarke SJ; Khaliulin I; Carroll CJ; Scarabelli TM; Knight RA; Stephanou A; Latchman DS; Halestrap AP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H928-38. PubMed ID: 17483234
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of myocardial ischemia reperfusion injury.
Hou M; Wu X; Zhao Z; Deng Q; Chen Y; Yin L
Acta Biomater; 2022 Apr; 143():344-355. PubMed ID: 35189380
[TBL] [Abstract][Full Text] [Related]
16. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes.
Zhao ZQ; Nakamura M; Wang NP; Wilcox JN; Shearer S; Guyton RA; Vinten-Johansen J
Coron Artery Dis; 1999 Dec; 10(8):617-28. PubMed ID: 10599541
[TBL] [Abstract][Full Text] [Related]
17. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
18. Reperfusion injury: experimental evidence and clinical implications.
Ambrosio G; Tritto I
Am Heart J; 1999 Aug; 138(2 Pt 2):S69-75. PubMed ID: 10426862
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of myocardial cell injury during ischemia and reperfusion.
Barry WH
J Card Surg; 1987 Sep; 2(3):375-83. PubMed ID: 2979987
[TBL] [Abstract][Full Text] [Related]
20. Mff-Dependent Mitochondrial Fission Contributes to the Pathogenesis of Cardiac Microvasculature Ischemia/Reperfusion Injury via Induction of mROS-Mediated Cardiolipin Oxidation and HK2/VDAC1 Disassociation-Involved mPTP Opening.
Zhou H; Hu S; Jin Q; Shi C; Zhang Y; Zhu P; Ma Q; Tian F; Chen Y
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
